T4327 |
Prexasertib dihydrochloride
|
1234015-54-3
|
97.5%
|
|
Prexasertib dihydrochloride (LY2606368) is an ATP-competitive CHK1 inhibitor (Ki: 0.9 nmol/L). in the cell-free assay, its IC50 values are 8 nM and 9 nM for CHK2...
|
T35329L |
EAD1 TFA(1644388-26-0 Free base)
|
2320427-95-8
|
97.49%
|
|
EAD1 HCL is a potent autophagy inhibitor with antiproliferative activity in lung and pancreatic cancer cells. EAD1 HCL also induces apoptosis
|
T10761 |
Ceranib-2
|
1402830-75-4
|
97.49%
|
|
Ceranib-2 (3-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]-4-phenyl-1H-quinolin-2-one) is an inhibitor of ceramidase with an IC50 of 28 μM in SKOV3 cells. Ceranib-2 decr...
|
T8956 |
BC-1258
|
1507370-40-2
|
97.48%
|
|
BC-1258 is a unique small molecule F-box/LRR-repeat protein 2 (FBXL2) activator.
|
T2160 |
Suramin Sodium Salt
|
129-46-4
|
97.47%
|
|
Suramin Sodium Salt (BAY-205) is a sodium salt form of suramin, a polysulphonated naphthylurea with potential antineoplastic activity. Suramin blocks the binding...
|
T9102 |
WM-3835
|
2229025-70-9
|
97.47%
|
|
WM-3835 is a novel and high-specific small molecule inhibitor of Lysine Acetyltransferase 7 (KAT7, MYST2, HBO1) , able to potently suppressed OS cell proliferati...
|
T2649 |
Menin-MLL inhibitor MI-2
|
1271738-62-5
|
97.46%
|
|
Menin-MLL inhibitor MI-2 (MI2) is a potent menin-MLL interaction inhibitor with IC50 of 446 nM.
|
T3375 |
Verbascoside
|
61276-17-3
|
97.46%
|
|
Verbascoside (Kusaginin) is a protein kinase C inhibitor with antimicrobial, anti-inflammatory activities.
|
T12085 |
MN58b
|
203192-01-2
|
97.46%
|
|
MN58b is a selective inhibitor of choline kinase α (CHKα).
|
TN1839 |
Kumatakenin
|
3301-49-3
|
97.44%
|
|
Kumatakenin can suppress >80% of the SOS-inducing activity of Trp-P-1 at <0.06 micromol/mL.
|
T16791 |
Rottlerin
|
82-08-6
|
97.41%
|
|
Rottlerin (NSC-56346) is a natural product purified from Mallotus Philippinensis and is a specific PKC inhibitor (IC50: PKCδ of 3-6 μM, PKCα,β,γ of 30-42 μM, PKC...
|
T8380 |
Bendamustine
|
16506-27-7
|
97.38%
|
|
Bendamustine (SDX105) for the treatment of Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia
|
T2392 |
Nafamostat mesylate
|
82956-11-4
|
97.36%
|
|
Nafamostat mesylate (FUT-175), a synthetic serine protease inhibitor, has been used for the treatment of allergic disorders such as asthma, allergic rhinitis and...
|
T16750 |
Rigosertib
|
592542-59-1
|
97.33%
|
|
Rigosertib (ON-01910) is a selective and non-ATP-competitive inhibitor of PLK1 (IC50: 9 nM). Rigosertib is a multi-kinase inhibitor and a selective anti-cancer a...
|
T6525 |
GW 5074
|
220904-83-6
|
97.3%
|
|
GW 5074 (Raf1 Kinase Inhibitor I)(IC50=9 nM) is an effective and specific c-Raf inhibitor. It has no effect on the activities of JNK1/2/3, MEK1, MKK6/7, CDK1/2, ...
|
T6787 |
BIO-acetoxime
|
667463-85-6
|
97.28%
|
|
BIO-acetoxime (GSK-3 Inhibitor X) is a potent dual GSK3α/β inhibitor with IC50 of 10 nM, >240-fold selectivity over CDK5/p25, CDK2/cyclin A and CDK1/cyclin B.
|
T12932L |
SM-164
|
957135-43-2
|
97.25%
|
|
SM-164 binds to XIAP protein containing both the BIR2 and BIR3 domains (IC50: 1.39 nM). It acts as an extremely potent antagonist of XIAP.
|
T2300 |
AZD1208
|
1204144-28-4
|
97.24%
|
|
AZD1208 is a novel, orally bioavailable, highly selective PIM kinase inhibitor with single nanomolar potency against all three PIM kinases.
|
T3572 |
NSC 15364
|
4550-72-5
|
97.22%
|
|
NSC 15364 (1,3-Bis(4-aminophenyl)urea) can be used for screening of ALR inhibitors by detection of hydrogen peroxide production Measured in Biochemical System.
|
T3S1416 |
Decursin
|
5928-25-6
|
97.22%
|
|
1. Decursin (Decursinol angelate) is able to attenuate kainic acid-induced seizures and could have potential as an antiepileptic drug. 2. Decursin exhibits hepat...
|